Your browser doesn't support javascript.
loading
Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates.
Wang, Yaguo; Li, Zihui; Wu, Shucai; Fleming, Joy; Li, Chuanyou; Zhu, Guofeng; Chen, Bo; Ren, Baiguang; Wang, Xingyun; Du, Boping; Li, Pingjun; Hu, Peilei; Yang, Juwang; Liu, Yi; Zhou, Chongchen; Zhang, Xian-En; Bi, Lijun; Zhang, Hongtai; Yang, Junmei; Zhang, Zongde.
Affiliation
  • Wang Y; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Li Z; University of Chinese Academy of Sciences, Beijing, China.
  • Wu S; Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Fleming J; Hebei Chest Hospital, Shijiazhuang, China.
  • Li C; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhu G; Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Chen B; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Ren B; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Wang X; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Du B; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Li P; Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Hu P; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Yang J; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Liu Y; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhou C; Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Zhang XE; Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan Province, China.
  • Bi L; National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhang H; School of Stomatology and Medicine, Foshan University, Foshan, Guangdong Province, China.
  • Yang J; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhang Z; National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Infect Immun ; 89(3)2021 02 16.
Article in En | MEDLINE | ID: mdl-33318140

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Tuberculosis / Tuberculosis Vaccines / Mycobacterium tuberculosis / Antigens, Bacterial Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Infect Immun Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Tuberculosis / Tuberculosis Vaccines / Mycobacterium tuberculosis / Antigens, Bacterial Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Infect Immun Year: 2021 Type: Article Affiliation country: China